Kinetic analysis of cytochrome P450 reductase from Artemisia annua reveals accelerated rates of NADH-dependent flavin reduction

FEBS Journal

Volumn 280, Issue 24, 2013, Pages 6627-6642

  Simtchouk, Svetlana ^a   Eng, Jordan L ^a   Meints, Carla E ^a   Makins, Caitlyn ^a   Wolthers, Kirsten R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Artemisia annua; cytochrome P450 reductase; flavin; potentiometry; stopped flow spectroscopy

Indexed keywords

CYTOCHROME P450 REDUCTASE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; QUERCETIN;

ABSORPTION SPECTROSCOPY; ARTEMISIA ANNUA; ARTICLE; BINDING AFFINITY; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME STRUCTURE; ESCHERICHIA COLI; HUMAN; MOLECULAR CLONING; MOLECULAR MECHANICS; NONHUMAN; POTENTIOMETRIC TITRATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN INTERACTION; PROTEIN PURIFICATION; STOPPED FLOW SPECTROSCOPY; THERMODYNAMICS;

ARTEMISIA ANNUA; CYTOCHROME P450 REDUCTASE; FLAVIN; POTENTIOMETRY; STOPPED-FLOW SPECTROSCOPY;

AMINO ACID SEQUENCE; ARTEMISIA ANNUA; ARTEMISININS; CLONING, MOLECULAR; ELECTRON TRANSPORT; FLAVINS; HUMANS; KINETICS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NAD; NADPH-FERRIHEMOPROTEIN REDUCTASE; OXIDATION-REDUCTION; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY, AMINO ACID; THERMODYNAMICS;

ARTEMISIA ANNUA; ESCHERICHIA COLI; MAMMALIA;

EID: 84889681811     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12567     Document Type: Article

References (59)

1. World Health Organization (2005) World Malaria Report 2011. World Health Organization, Geneva.
2. Enserink M, (2005) Infectious diseases Source of new hope against malaria is in short supply. Science 307, 33.
3. Ro DK, Paradise EM, Ouellet M, Fisher KJ, Newman KL, Ndungu JM, Ho KA, Eachus RA, Ham TS, Kirby J, et al,. (2006) Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 440, 940-943.
4. Chang MC, Eachus RA, Trieu W, Ro DK, &, Keasling JD, (2007) Engineering Escherichia coli for production of functionalized terpenoids using plant P450s. Nat Chem Biol 3, 274-277.
5. Mercke P, Bengtsson M, Bouwmeester HJ, Posthumus MA, &, Brodelius PE, (2000) Molecular cloning, expression, and characterization of amorpha-4,11-diene synthase, a key enzyme of artemisinin biosynthesis in Artemisia annua L. Arch Biochem Biophys 381, 173-180.
6. Murataliev MB, Feyereisen R, &, Walker FA, (2004) Electron transfer by diflavin reductases. Biochim Biophys Acta 1698, 1-26.
7. Gutierrez A, Grunau A, Paine M, Munro AW, Wolf CR, Roberts GC, &, Scrutton NS, (2003) Electron transfer in human cytochrome P450 reductase. Biochem Soc Trans 31, 497-501.
8. Pudney CR, Heyes DJ, Khara B, Hay S, Rigby SE, &, Scrutton NS, (2012) Kinetic and spectroscopic probes of motions and catalysis in the cytochrome P450 reductase family of enzymes. FEBS J 279, 1534-1544.
9. Masters BS, Bilimoria MH, Kamin H, &, Gibson QH, (1965) The mechanism of 1- and 2-electron transfers catalyzed by reduced triphosphopyridine nucleotide-cytochrome c reductase. J Biol Chem 240, 4081-4088.
10. Iyanagi T, &, Mason HS, (1973) Some properties of hepatic reduced nicotinamide adenine dinucleotide phosphate-cytochrome c reductase. Biochemistry 12, 2297-2308.
11. Vermilion JL, &, Coon MJ, (1978) Identification of the high and low potential flavins of liver microsomal NADPH-cytochrome P-450 reductase. J Biol Chem 253, 8812-8819.
12. Ro DK, Ehlting J, &, Douglas CJ, (2002) Cloning, functional expression, and subcellular localization of multiple NADPH-cytochrome P450 reductases from hybrid poplar. Plant Physiol 130, 1837-1851.
13. Urban P, Mignotte C, Kazmaier M, Delorme F, &, Pompon D, (1997) Cloning, yeast expression, and characterization of the coupling of two distantly related Arabidopsis thaliana NADPH-cytochrome P450 reductases with P450 CYP73A5. J Biol Chem 272, 19176-19186.
14. Benveniste I, Lesot A, Hasenfratz MP, Kochs G, &, Durst F, (1991) Multiple forms of NADPH-cytochrome P450 reductase in higher plants. Biochem Biophys Res Commun 177, 105-112.
15. Guengerich FP, (1994) Catalytic selectivity of human cytochrome P450 enzymes: relevance to drug metabolism and toxicity. Toxicol Lett 70, 133-138.
16. Park HG, Lim YR, Eun CY, Han S, Han JS, Cho KS, Chun YJ, &, Kim D, (2010) Candida albicans NADPH-P450 reductase: expression, purification, and characterization of recombinant protein. Biochem Biophys Res Commun 396, 534-538.
17. Williams CH Jr, &, Kamin H, (1962) Microsomal triphosphopyridine nucleotide-cytochrome c reductase of liver. J Biol Chem 237, 587-595.
18. Wang M, Roberts DL, Paschke R, Shea TM, Masters BS, &, Kim JJ, (1997) Three-dimensional structure of NADPH-cytochrome P450 reductase: prototype for FMN- and FAD-containing enzymes. Proc Natl Acad Sci USA 94, 8411-8416.
19. Xia C, Panda SP, Marohnic CC, Martasek P, Masters BS, &, Kim JJ, (2011) Structural basis for human NADPH-cytochrome P450 oxidoreductase deficiency. Proc Natl Acad Sci USA 108, 13486-13491.
20. Hamdane D, Xia C, Im SC, Zhang H, Kim JJ, &, Waskell L, (2009) Structure and function of an NADPH-cytochrome P450 oxidoreductase in an open conformation capable of reducing cytochrome P450. J Biol Chem 284, 11374-11384.
21. Grunau A, Paine MJ, Ladbury JE, &, Gutierrez A, (2006) Global effects of the energetics of coenzyme binding: NADPH controls the protein interaction properties of human cytochrome P450 reductase. Biochemistry 45, 1421-1434.
22. Grunau A, Geraki K, Grossmann JG, &, Gutierrez A, (2007) Conformational dynamics and the energetics of protein-ligand interactions: role of interdomain loop in human cytochrome P450 reductase. Biochemistry 46, 8244-8255.
23. Xia C, Hamdane D, Shen AL, Choi V, Kasper CB, Pearl NM, Zhang H, Im SC, Waskell L, &, Kim JJ, (2011) Conformational changes of NADPH-cytochrome P450 oxidoreductase are essential for catalysis and cofactor binding. J Biol Chem 286, 16246-16260.
24. Ellis J, Gutierrez A, Barsukov IL, Huang WC, Grossmann JG, &, Roberts GC, (2009) Domain motion in cytochrome P450 reductase: conformational equilibria revealed by NMR and small-angle x-ray scattering. J Biol Chem 284, 36628-36637.
25. Vincent B, Morellet N, Fatemi F, Aigrain L, Truan G, Guittet E, &, Lescop E, (2012) The closed and compact domain organization of the 70-kDa human cytochrome P450 reductase in its oxidized state as revealed by NMR. J Mol Biol 420, 296-309.
26. Shen AL, &, Kasper CB, (1995) Role of acidic residues in the interaction of NADPH-cytochrome P450 oxidoreductase with cytochrome P450 and cytochrome c. J Biol Chem 270, 27475-27480.
27. Louerat-Oriou B, Perret A, &, Pompon D, (1998) Differential redox and electron-transfer properties of purified yeast, plant and human NADPH-cytochrome P-450 reductases highly modulate cytochrome P-450 activities. Eur J Biochem 258, 1040-1049.
28. Murataliev MB, Arino A, Guzov VM, &, Feyereisen R, (1999) Kinetic mechanism of cytochrome P450 reductase from the house fly (Musca domestica). Insect Biochem Mol Biol 29, 233-242.
29. Dohr O, Paine MJ, Friedberg T, Roberts GC, &, Wolf CR, (2001) Engineering of a functional human NADH-dependent cytochrome P450 system. Proc Natl Acad Sci USA 98, 81-86.
30. Shen AL, Christensen MJ, &, Kasper CB, (1991) NADPH-cytochrome P-450 oxidoreductase. The role of cysteine 566 in catalysis and cofactor binding. J Biol Chem 266, 19976-19980.
31. Marohnic CC, Panda SP, Martasek P, &, Masters BS, (2006) Diminished FAD binding in the Y459H and V492E Antley-Bixler syndrome mutants of human cytochrome P450 reductase. J Biol Chem 281, 35975-35982.
32. Shen AL, Sem DS, &, Kasper CB, (1999) Mechanistic studies on the reductive half-reaction of NADPH-cytochrome P450 oxidoreductase. J Biol Chem 274, 5391-5398.
33. Murataliev MB, &, Feyereisen R, (2000) Interaction of NADP(H) with oxidized and reduced P450 reductase during catalysis Studies with nucleotide analogues. Biochemistry 39, 5066-5074.
34. Deng Z, Aliverti A, Zanetti G, Arakaki AK, Ottado J, Orellano EG, Calcaterra NB, Ceccarelli EA, Carrillo N, &, Karplus PA, (1999) A productive NADP+ binding mode of ferredoxin-NADP+reductase revealed by protein engineering and crystallographic studies. Nat Struct Biol 6, 847-853.
35. Wolthers KR, Lou XD, Toogood HS, Leys D, &, Scrutton NS, (2007) Mechanism of coenzyme binding to human methionine synthase reductase revealed through the crystal structure of the FNR-like module and isothermal titration calorimetry. Biochemistry 46, 11833-11844.
36. Lian LY, Widdowson P, McLaughlin LA, &, Paine MJ, (2011) Biochemical comparison of Anopheles gambiae and human NADPH P450 reductases reveals different 2′-5′-ADP and FMN binding traits. PLoS ONE 6, e20574.
37. Arnold K, Bordoli L, Kopp J, &, Schwede T, (2006) The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22, 195-201.
38. Meints CE, Gustafsson FS, Scrutton NS, &, Wolthers KR, (2011) Tryptophan 697 modulates hydride and interflavin electron transfer in human methionine synthase reductase. Biochemistry 50, 11131-11142.
39. Martinez-Julvez M, Tejero J, Peregrina JR, Nogues I, Frago S, Gomez-Moreno C, &, Medina M, (2005) Towards a new interaction enzyme:coenzyme. Biophys Chem 115, 219-224.
40. Sem DS, &, Kasper CB, (1993) Interaction with arginine 597 of NADPH-cytochrome P-450 oxidoreductase is a primary source of the uniform binding energy used to discriminate between NADPH and NADH. Biochemistry 32, 11548-11558.
41. Adak S, Sharma M, Meade AL, &, Stuehr DJ, (2002) A conserved flavin-shielding residue regulates NO synthase electron transfer and nicotinamide coenzyme specificity. Proc Natl Acad Sci USA 99, 13516-13521.
42. Neeli R, Roitel O, Scrutton NS, &, Munro AW, (2005) Switching pyridine nucleotide specificity in P450 BM3: mechanistic analysis of the W1046H and W1046A enzymes. J Biol Chem 280, 17634-17644.
43. Iyanagi T, Makino N, &, Mason HS, (1974) Redox properties of the reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 and reduced nicotinamide adenine dinucleotide-cytochrome b5 reductases. Biochemistry 13, 1701-1710.
44. Munro AW, Noble MA, Robledo L, Daff SN, &, Chapman SK, (2001) Determination of the redox properties of human NADPH-cytochrome P450 reductase. Biochemistry 40, 1956-1963.
45. Oprian DD, &, Coon MJ, (1982) Oxidation-reduction states of FMN and FAD in NADPH-cytochrome P-450 reductase during reduction by NADPH. J Biol Chem 257, 8935-8944.
46. Gutierrez A, Lian LY, Wolf CR, Scrutton NS, &, Roberts GC, (2001) Stopped-flow kinetic studies of flavin reduction in human cytochrome P450 reductase and its component domains. Biochemistry 40, 1964-1975.
47. Lee SY, Kim HU, Park JH, Park JM, &, Kim TY, (2009) Metabolic engineering of microorganisms: general strategies and drug production. Drug Discov Today 14, 78-88.
48. Ajikumar PK, Tyo K, Carlsen S, Mucha O, Phon TH, &, Stephanopoulos G, (2008) Terpenoids: opportunities for biosynthesis of natural product drugs using engineered microorganisms. Mol Pharm 5, 167-190.
49. Morant M, Bak S, Moller BL, &, Werck-Reichhart D, (2003) Plant cytochromes P450: tools for pharmacology, plant protection and phytoremediation. Curr Opin Biotechnol 14, 151-162.
50. Mizutani M, &, Sato F, (2011) Unusual P450 reactions in plant secondary metabolism. Arch Biochem Biophys 507, 194-203.
51. Mizutani M, &, Ohta D, (2010) Diversification of P450 genes during land plant evolution. Annu Rev Plant Biol 61, 291-315.
52. Sevrioukova I, Shaffer C, Ballou DP, &, Peterson JA, (1996) Equilibrium and transient state spectrophotometric studies of the mechanism of reduction of the flavoprotein domain of P450BM-3. Biochemistry 35, 7058-7068.
53. Brenner S, Hay S, Munro AW, &, Scrutton NS, (2008) Inter-flavin electron transfer in cytochrome P450 reductase-effects of solvent and pH identify hidden complexity in mechanism. FEBS J 275, 4540-4557.
54. Phillips AH, &, Langdon RG, (1962) Hepatic triphosphopyridine nucleotide-cytochrome c reductase: isolation, characterization, and kinetic studies. J Biol Chem 237, 2652-2660.
55. Sem DS, &, Kasper CB, (1995) Effect of ionic strength on the kinetic mechanism and relative rate limitation of steps in the model NADPH-cytochrome P450 oxidoreductase reaction with cytochrome c. Biochemistry 34, 12768-12774.
56. Viola RE, Cook PF, &, Cleland WW, (1979) Stereoselective preparation of deuterated reduced nicotinamide adenine nucleotides and substrates by enzymatic synthesis. Anal Biochem 96, 334-340.
57. Olteanu H, &, Banerjee R, (2001) Human methionine synthase reductase, a soluble P-450 reductase-like dual flavoprotein, is sufficient for NADPH-dependent methionine synthase activation. J Biol Chem 276, 35558-35563.
58. Dutton PL, (1978) Redox potentiometry: determination of midpoint potentials of oxidation-reduction components of biological electron-transfer systems. Methods Enzymol 54, 411-435.
59. Daff SN, Chapman SK, Turner KL, Holt RA, Govindaraj S, Poulos TL, &, Munro AW, (1997) Redox control of the catalytic cycle of flavocytochrome P-450 BM3. Biochemistry 36, 13816-13823.